Related Experiment Video
Updated: Oct 27, 2025

08:09
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
7.7K
Corrigendum: Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation
Yajing Chen1, Tingting Wu1, Heng Li2
1Department of Neurology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Frontiers in Aging Neuroscience
|July 23, 2021
Abstract:
[This corrects the article DOI: 10.3389/fnagi.2019.00044.].
Insights
This study corrects a previous article DOI. The corrected DOI is 10.3389/fnagi.2019.00044.
Area of Science:
- Neuroscience
- Genetics
Context:
- Correction of a previously published article DOI.
- Ensuring accurate citation and retrieval of scientific literature.
Purpose:
- To provide the correct Digital Object Identifier (DOI) for a specific scientific article.
- To rectify an error in the citation details of published research.
Summary:
- The article DOI 10.3389/fnagi.2019.00044 has been corrected.
- This ensures proper referencing for the research published in this journal.
Impact:
- Facilitates accurate citation and access to the corrected article.
- Maintains the integrity and traceability of scientific publications.
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
1.7K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.7K
Parkinson's Disease: Treatment
569
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
569

